FERRONE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 8.809
AS - Asia 3.903
EU - Europa 3.724
SA - Sud America 482
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 87
OC - Oceania 5
Totale 17.130
Nazione #
US - Stati Uniti d'America 8.711
SG - Singapore 1.491
CN - Cina 941
SE - Svezia 824
UA - Ucraina 737
IT - Italia 497
BR - Brasile 372
VN - Vietnam 349
HK - Hong Kong 346
FI - Finlandia 332
KR - Corea 303
DE - Germania 282
FR - Francia 264
GB - Regno Unito 147
PL - Polonia 130
TR - Turchia 130
RU - Federazione Russa 127
BG - Bulgaria 111
IE - Irlanda 107
IN - India 70
BD - Bangladesh 49
AR - Argentina 45
CA - Canada 41
MY - Malesia 41
NL - Olanda 34
BE - Belgio 33
IQ - Iraq 33
CH - Svizzera 28
JP - Giappone 26
ZA - Sudafrica 21
MX - Messico 19
EC - Ecuador 17
UZ - Uzbekistan 16
MA - Marocco 15
CO - Colombia 14
CZ - Repubblica Ceca 13
KE - Kenya 12
PH - Filippine 12
PK - Pakistan 11
EG - Egitto 10
ID - Indonesia 10
JM - Giamaica 10
JO - Giordania 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
ES - Italia 8
HN - Honduras 8
PY - Paraguay 8
TH - Thailandia 8
DZ - Algeria 7
IL - Israele 7
KZ - Kazakistan 7
EU - Europa 6
LT - Lituania 6
RO - Romania 6
ET - Etiopia 5
KG - Kirghizistan 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
BB - Barbados 3
GR - Grecia 3
IR - Iran 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PR - Porto Rico 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
LC - Santa Lucia 2
LV - Lettonia 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
Totale 17.004
Città #
Woodbridge 1.206
Ann Arbor 1.120
Singapore 840
Ashburn 636
Jacksonville 629
Houston 588
San Jose 552
Chandler 508
Fairfield 363
Hong Kong 345
Seoul 301
Hefei 277
Wilmington 273
Beijing 220
Princeton 210
Boardman 185
Council Bluffs 180
Columbus 154
Seattle 149
Chicago 144
Ho Chi Minh City 113
Cambridge 110
Sofia 110
Helsinki 108
Dublin 104
Zgierz 103
Lauterbourg 99
Los Angeles 93
Milan 86
Izmir 85
Hanoi 71
Düsseldorf 65
Buffalo 63
Moscow 62
Munich 59
Dearborn 57
The Dalles 53
Dallas 51
Frankfurt am Main 43
Falkenstein 42
New York 42
San Diego 40
Santa Clara 39
São Paulo 36
Redwood City 34
Bremen 33
Brussels 33
Kocaeli 29
Orem 29
Chennai 28
Trieste 26
Bern 23
Tokyo 23
Warsaw 23
Verona 22
Phoenix 21
Shanghai 20
Haiphong 19
Des Moines 16
Falls Church 16
Guangzhou 16
Nanjing 16
Amsterdam 15
Rome 15
Da Nang 14
Montreal 14
Redondo Beach 14
Turku 14
Brno 12
London 12
Miano 12
Mumbai 12
Tashkent 12
Belo Horizonte 11
Charlotte 11
Nairobi 11
Norwalk 11
Casablanca 10
Jinan 10
Quito 10
Rio de Janeiro 10
Tianjin 10
Amman 9
Brooklyn 9
Florence 9
Johannesburg 9
Naples 9
Baghdad 8
Boston 8
Brasília 8
Curitiba 8
Manchester 8
Nanchang 8
San Francisco 8
Toronto 8
Biên Hòa 7
Can Tho 7
Cape Town 7
Denver 7
Fremont 7
Totale 11.425
Nome #
POLIMERI IN MEDICINA I DENDRIMERI, UN ESEMPIO DI MOLECOLE BIOTECNOLOGICHE 279
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 271
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach 268
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 265
Binding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers 259
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 232
C-kit mutants in GISTs and their interaction with STI 571: Insights from computer simulations and clinical trials. 227
"Fatty" nucleoside analogs as HCV NS5b inhibitors 226
T670X kit mutations in gastrointestinal stromal tumors: making sense of missense 222
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors 215
Functional analysis and molecular modelling show a preserved wild type activity of p53 C238Y 214
Many-Scale Simulation of ABS/PC Blends for the Automotive Industry 208
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation 203
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 201
Chemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications. 201
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 196
PET/PEN Blends of Industrial Interest as Barrier Materials. Part I. Many-Scale Molecular Modeling of PET/PEN Blends 196
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm 195
Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy 193
A new twist for an old song. The DABO story revisited 193
A cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling 191
Synthesis and physico-chemical characterization of folate-cyclodextrin bioconjugate for active drug delivery 190
Functional analyses and Molecular modeling of two c-Kit mutations responsible for Imatinib secondary resistance in GIST patients 190
Integrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example 189
Can inhibitors of HIV integrase work on HCV polymerase? 185
Diblock copolymers for the automotive industry: the mesoscopic approach 184
Design, synthesis and preliminary in vitro and in silico antiviral activity of [4,7]phenantrolines and 1-oxo-1,4-dihydro-[4,7]phenantrolines against a single-stranded positive sense RNA genome viruses 183
Design, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp 183
Design, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts 183
Computer Simulation of nylon/organoclay nanocomposites: prediction of the binding energy 180
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer. 180
Upgrading polymeric materials from post industrial rejects: a multiscale simulation approach 180
Computer simulation of polymer-organoclay nanocomposites for packaging applications: From binding energy to interlayer spacing predictions 179
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm 179
A Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations 178
Grand canonical Monte Carlo simulations for VOCs adsorption in non-polar zeolites 177
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding 177
TT315I mutated bcr-abl in chronic myeloid leukemia and imatinib: insights from a computational study 172
Studying enzyme enantioselectivity using combined ab initio and free energy calculations: alfa-chymotrypsin and methyl cis- and trans-5-oxo-2-pentylpirrolidine-3-carboxylates 172
Alternative Refrigerants: Thermophysical Properties and Phase equilibra by computational chemistry 172
Delivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems 171
Computer-aided simulation of a dendrimer with a protoporphyrinic core as potential, novel hemoprotein mimic. 169
Molecular Simulation of Atrazine Adhesion and Diffusion in a Saturated Sand Model 169
Three-dimensional, nanosized phenylene-based dendrimers: scaling properties studied by a computational approach 169
Design, synthesis and anti flaviviridae activity of N6-, -O- and 5 O-substituted adenine nucleoside analogs 168
Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants 167
Nanocompositi: da micro a mesoscala 167
Polymer-Clay Nanocomposites Based on PEO-Diacrylate Macromolecules: a Combined Computational/Experimental Study 166
New materials from multiscale modelling procedures: properties prediction and customisation of polymeric nanocomposites 165
Genotype-phenotype correlations of myosin mutations: a molecular simulation study 161
Development of an all-atoms force field from ab-initio calculations for alterative refrigerants 160
Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations 160
Computational studies on the enantioselectivity of alpha-chymotrypsin towards beta-carbomethoxy-gamma-lactams. 159
GCMC Simulations in Zeolite MFI and Activated Carbon for Benzene Removal from Exhaust Gaseous Streams 158
Release of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation 158
Nano-scaled inorganic/biopolymer composites: Molecular modeling vistas 158
Changes and challenges: GIST, mutated C-KIT and imatinib resistance 158
Prediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale 156
Innovative procedures based on advanced mesoscale simulation techniques for functional polymers in automotive industry 155
How the Angstrom modifies the nano: effect of point mutations on the nanodimensional structure of human TP53 point mutations 154
Enantiomerically pure beta,gamma-disubstituted gamma-lactams: Enzyme-mediated synthesis and computational studies 154
Probing the activity of diketoacis as HCV NS5B polymerase inhibitors via detailed molecular modeling 152
Simulation insight on the structure and energetics of biocompatible polymer nanocomposite systems 150
Hydrogen sulphide removal from biogas by zeolite adsorption: part I. GCMC molecular simulations 149
Modellazione molecolare e progettazione di nuovi inibitori della serin proteasi NS3 del virus dell’HCV 146
Molecular modeling of Nylon 6/organoclay nanocomposite: prediction of binding energy 144
SYNTHESIS AND ANTI-PICORNAVIRIDAE IN VITRO ACTIVITY OF A NEW CLASS OF HELICASE INHIBITORS THE N,N’-BIS-[4-1H(2H)-BENZOTRIAZOL-1(2)-YL)PHENYL] ALKYLDICARBOXAMIDES. 144
Of life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm 144
PVC/LDPE incompatible blends for industrial applications: A computational multiscale approach 141
Where are we in HIV research? A novel, computer-based strategy predicting resistance to HIV-1 NNRTIs 140
Shape-persistent polyphenylene-based dendrimers: a computational approach 140
Human TP53 point mutations: structural analysis by molecular modelling 140
Scaling properties in the molecular structure of three-dimensional, nanosized phenylene-based dendrimers as studied by atomistic molecular dynamics simulations 139
Take a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy 138
Molecular modeling of hydrogen storage in carbon nanotubes: A combined molecular dynamics/ab initio orbital study 136
Odor emission removal from gaseous streams by the use of zeolites: A molecular simulation approach 136
Computational alanine scanning to probe DNA - Wild type and mutant p53 interactions. 135
P53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale 135
Hydrogen sulphide removal from biogas by zeolite adsorption: part II. A MD simulation 134
Using of MM-PBSA in reproducing the binding free energy of NSAIDS to beta-cyclodextrin. 134
Estimation of the binding energy in random poly(butylene terephtalate-co-thiodiethylene terephtalate) copolyesters/clay nanocomposites via molecular simulations 133
Enantioselectivity of alpha-chytripsyn towards 4,5-disubstituted-gamma-lactams: a new perspective from molecular simulations 133
Molecular simulation techniques for sustainable technology and environmental applications: general overview and case studies 132
Computational studies of shape-persistent polyphenylene dendrimers 132
Synthesis of a New Series of Nucleoside Analogs with Antiflaviviridae Activity and Their Interaction with RNA-Dependent RNA-Polymerase 130
Shape-persistent polyphenylene dendrimers: a computational study 127
Molecular dynamics and free energy analyses of the interactions between beta-cyclodextrin and some anticancer drugs. 126
Upgrading block co-polymers from post industrial rejects: a multiscale simulation approach 125
Synthesis, characterization and molecular modeling of a cyclodextrin-bioconjugate as anticancer drug 124
Prediction of thermophysical properties of alternative refrigerants by a novel, ab initio force field 123
Three-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase 123
Design, synthesis and activity of phosphonoacetic acid (Ppa) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors 120
Host-guest inclusion complexes between anticancer drugs and beta-cytclodextrin: computational studies. 120
Detailed Molecular Modeling of Point Mutations of P53 119
Diffusion of proteins in nanochannels. A many-scale simulation approach 119
Ribonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates 119
Towards Dendrimers as Anticancer Drug Carriers: from in Silico to in Vivo Characterization 118
Computer-assisted design of new, potential HCV inhibitors 117
Hindered Nucleoside Analogs (HNA) as Antiflaviviridae Agents 113
Nylon-6/organoclay nanocomposites: prediction of the binding energy by molecular simulation 113
Totale 16.633
Categoria #
all - tutte 51.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 0 112 135 13 84 44 41 172 114 52 241
2022/20231.542 141 148 112 207 227 257 13 113 207 16 74 27
2023/2024684 67 48 39 55 86 39 72 154 6 8 43 67
2024/20251.886 41 24 60 199 238 219 126 81 272 206 162 258
2025/20264.786 469 346 342 445 425 498 582 167 617 671 123 101
2026/2027706 126 234 346 0 0 0 0 0 0 0 0 0
Totale 17.130